Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Alcalay RN"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-17 z 17
    Tytuł:
    Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson's Disease Project.
    Autorzy:
    Vollstedt EJ; Institute of Neurogenetics, University of Luebeck, Luebeck, Germany.
    Madoev H; Institute of Neurogenetics, University of Luebeck, Luebeck, Germany.
    Aasly A; Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway.
    Ahmad-Annuar A; Department of Biomedical Science, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
    Al-Mubarak B; Center for Genomic Medicine, Research Centre, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
    Alcalay RN; Department of Neurology, Columbia University, New York, New York, United States of America.; Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel; Sackler School of Medicine, Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv, Israel.
    Alvarez V; Laboratório de Genética, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain.; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
    Amorin I; Universidad de la Republica Uruguay, Montevideo, Uruguay.
    Annesi G; Institute of Biomedical Research and Innovation, National Research Council, Cosenza, Italy.
    Arkadir D; Department of Neurology, Hadassah Medical Center and the Hebrew University, Jerusalem, Israel.
    Bardien S; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.; South African Medical Research Council/Stellenbosch University Genomics of Brain Disorders Research Unit, Stellenbosch University, Cape Town, South Africa.
    Barker RA; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.
    Barkhuizen M; DST/NWU Preclinical Drug Development Platform, North-West University, Potchefstroom, North-West, South Africa.
    Basak AN; Suna and Inan Kiraç Foundation, Neurodegeneration Research Laboratory, KUTTAM, School of Medicine, Koç University, Istanbul, Turkey.
    Bonifati V; Department of Clinical Genetics, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
    Boon A; Department of Neurology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
    Brighina L; Department of Neurology, Milan Center for Neuroscience, University of Milano-Bicocca/San Gerardo Hospital, Monza, Monza Brianza, Italy.
    Brockmann K; Department of Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Baden Wuerttemberg, Germany.; Hertie Institute for Clinical Brain Research and German Centre for Neurodegenerative Diseases, Tuebingen, Baden Wuerttemberg, Germany.
    Carmine Belin A; Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
    Carr J; South African Medical Research Council/Stellenbosch University Genomics of Brain Disorders Research Unit, Stellenbosch University, Cape Town, South Africa.; Division of Neurology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
    Clarimon J; Department of Neurology, Biomedical Research Institute IIB-Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
    Cornejo-Olivas M; Neurogenetics Research Center, Instituto Nacional de Ciencias Neurologicas, Lima, Peru.; Center for Global Health, Universidad Peruana Cayetano Heredia, Lima, Peru.
    Correia Guedes L; Centro de Estudos Egas Moniz, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.; Instituto de Medicina Molecular João Lobo Antunes, Faculty of Medicine, University of Lisbon, Lisbon, Portugal.
    Corvol JC; Paris Brain Institute-ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Department of Neurology, Sorbonne University, Paris, France.
    Crosiers D; Department of Neurology, Antwerp University Hospital, Edegem, Belgium.; Translational Neurosciences, Born Bunge Institute, Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Antwerp, Belgium.; Center for Molecular Neurology, VIB, Wilrijk, Antwerp, Belgium.
    Damásio J; Department of Neurology, Hospital de Santo António-Centro Hospitalar Universitário do Porto, Porto, Portugal.; UnIGENe, Instituto de Biologia Molecular e Celular (IBMC), Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, Porto, Portugal.
    Das P; Centre for Genetic Disorders, Institute of Science, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
    de Carvalho Aguiar P; Hospital Israelita Albert Einstein, São Paulo, Brazil.; Department of Neurology and Neurosurgery, Universidade Federal de São Paulo, São Paulo, Brazil.
    De Rosa A; Department of Neurosciences and Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy.
    Dorszewska J; Laboratory of Neurobiology, Department of Neurology, Poznan University of Medical Sciences, Poznan, Poland.
    Ertan S; Department of Neurology, School of Medicine, Koç University, Istanbul, Turkey.
    Ferese R; IRCCS Neuromed, Localita' Camerelle, Pozzilli, Isernia, Italy.
    Ferreira J; Translational Neurosciences, Born Bunge Institute, Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Antwerp, Belgium.; Laboratory of Clinical Pharmacology and Therapeutics, University of Lisbon, Lisbon, Portugal.
    Gatto E; Movement Disorders, Department of Neurology, Instituto de Neurosciencias Buenos Aires, Buenos Aires, Argentina.
    Genç G; Department of Neurology, University of Health Sciences, Şişli Hamidiye Etfal Training and Research Hospital, İstanbul, Turkey.
    Giladi N; Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel; Sackler School of Medicine, Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv, Israel.
    Gómez-Garre P; Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
    Hanagasi H; Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
    Hattori N; Department of Neurology, Juntendo University School of Medicine, Bunkyo, Tokyo, Japan.
    Hentati F; Mongi Ben Hmida National Institute of Neurology, Tunis, Tunisia.
    Hoffman-Zacharska D; Institute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, Warsaw, Poland.
    Illarioshkin SN; Department of Neurogenetics, Research Center of Neurology, Moscow, Russia.
    Jankovic J; Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, United States of America.
    Jesús S; Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
    Kaasinen V; Neurocenter, Turku University Hospital, Turku, Finland.; Department of Neurology, Satasairaala Hospital, Pori, Finland.; Clinical Neurosciences, Faculty of Medicine, University of Turku, Turku, Finland.
    Kievit A; Department of Clinical Genetics, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
    Klivenyi P; Department of Neurology, University of Szeged, Szeged, Hungary.
    Kostic V; Department for Neurodegeneration, Clinic for Neurology UCCS, Medical Faculty, University of Belgrade, Belgrade, Serbia.
    Koziorowski D; Department of Neurology, Faculty of Health Science, Medical University in Warsaw, Warsaw, Poland.
    Kühn AA; Movement Disorder and Neuromodulation Unit, Charité, Department of Neurology, Campus Mitte, Universitätsmedizin Berlin, Berlin, Germany.
    Lang AE; Edmond J. Safra Program in Parkinson's Disease, Division of Neurology, Department of Medicine, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.
    Lim SY; Division of Neurology, Department of Medicine, and the Mah Pooi Soo & Tan Chin Nam Centre for Parkinson's & Related Disorders, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
    Lin CH; Department of Neurology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
    Lohmann K; Institute of Neurogenetics, University of Luebeck, Luebeck, Germany.
    Markovic V; Department for Neurodegeneration, Clinic for Neurology UCCS, Medical Faculty, University of Belgrade, Belgrade, Serbia.
    Martikainen MH; Neurocenter, Turku University Hospital, Turku, Finland.; Clinical Neurosciences, Faculty of Medicine, University of Turku, Turku, Finland.; Pontificia Universidad Católica Argentina (UCA), Buenos Aires, Argentina.
    Mellick G; Griffith Institute for Drug Discovery (GRIDD), School of Environment and Science, Griffith University, Brisbane, Queensland, Australia.
    Merello M; Pontificia Universidad Católica Argentina (UCA), Buenos Aires, Argentina.; Sección Movimientos Anormales, Departamento de Neurociencias, Fleni, Buenos Aires, Argentina.; Argentine National Scientific and Technological Research Council (CONICET), Buenos Aires, Argentina.
    Milanowski L; Department of Neurology, Faculty of Health Science, Medical University in Warsaw, Warsaw, Poland.
    Mir P; Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
    Öztop-Çakmak Ö; Department of Neurology, School of Medicine, Koç University, Istanbul, Turkey.
    Pimentel MMG; Department of Genetics, Institute of Biology Roberto Alcantara Gomes, State University of Rio de Janeiro, Rio de Janeiro, Brazil.
    Pulkes T; Division of Neurology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Rajthevi, Bangkok, Thailand.
    Puschmann A; Department of Neurology, Lund University, Lund, Sweden.; Department of Neurology, Skåne University Hospital, Lund, Sweden.
    Rogaeva E; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada.
    Sammler EM; Medical Research Council Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee, United Kingdom.; Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom.
    Skaalum Petersen M; Centre of Health Science, University of the Faroe Islands, Tórshavn, Faroe Islands.; Department of Occupational Medicine and Public Health, The Faroese Hospital System, Tórshavn, Faroe Islands.
    Skorvanek M; Pavol Jozef Šafárik University in Košice, Košice, Slovakia.; Department of Neurology, University Hospital L. Pasteur, Kosice, Slovakia.
    Spitz M; Neurology Service, State University of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.
    Suchowersky O; Department of Medicine, Medical Genetics and Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
    Tan AH; Division of Neurology, Department of Medicine, and the Mah Pooi Soo & Tan Chin Nam Centre for Parkinson's & Related Disorders, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
    Termsarasab P; Division of Neurology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Rajthevi, Bangkok, Thailand.
    Thaler A; Neurological Institute, Tel-Aviv Medical Center, Tel-Aviv, Israel; Sackler School of Medicine, Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv, Israel.
    Tumas V; Behavioral and Movement Disorders Section, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
    Valente EM; Department of Molecular Medicine, University of Pavia, Pavia, Italy.; Neurogenetics Research Centre, IRCCS Mondino Foundation, Pavia, Italy.
    van de Warrenburg B; Department of Neurology, Donders Institute for Brain, Cognition, and Behavior, Radboud University Medical Centre, Nijmegen, The Netherlands.
    Williams-Gray CH; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.
    Wu RM; Department of Neurology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
    Zhang B; Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
    Zimprich A; Department of Neurology, Medical University, Vienna, Austria.
    Solle J; The Michael J. Fox Foundation for Parkinson's Research, New York, NY, United States of America.
    Padmanabhan S; The Michael J. Fox Foundation for Parkinson's Research, New York, NY, United States of America.
    Klein C; Institute of Neurogenetics, University of Luebeck, Luebeck, Germany.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2023 Oct 03; Vol. 18 (10), pp. e0292180. Date of Electronic Publication: 2023 Oct 03 (Print Publication: 2023).
    Typ publikacji:
    Systematic Review; Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Parkinson Disease*/genetics
    Parkinson Disease*/therapy
    Humans ; Palliative Care
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Toward a biomarker panel measured in CNS-originating extracellular vesicles for improved differential diagnosis of Parkinson's disease and multiple system atrophy.
    Autorzy:
    Taha HB; Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.; Department of Integrative Biology and Physiology, University of California Los Angeles, Los Angeles, CA, 90095, USA.
    Hornung S; Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.; Division of Peptide Biochemistry, TUM School of Life Sciences, Technical University of Munich, 85354, Freising, Germany.
    Dutta S; Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.
    Fenwick L; Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.
    Lahgui O; Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.
    Howe K; Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.
    Elabed N; Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.
    Del Rosario I; Department of Epidemiology, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, 90095, USA.
    Wong DY; Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.; Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.
    Duarte Folle A; Department of Epidemiology, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, 90095, USA.
    Markovic D; Department of Medicine Statistics Core, Division of General Internal Medicine and Health Services Research, University of California Los Angeles, Los Angeles, CA, 90095, USA.
    Palma JA; Department of Neurology, Dysautonomia Center, New York University School of Medicine, New York, NY, 10016, USA.
    Kang UJ; Department of Neurology, The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, New York University School of Medicine, New York, NY, 10016, USA.
    Alcalay RN; Department of Neurology, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY, 10032, USA.; Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
    Sklerov M; Department of Neurology, University of North Carolina School of Medicine, Chapel Hill, NC, 27599, USA.
    Kaufmann H; Department of Neurology, Dysautonomia Center, New York University School of Medicine, New York, NY, 10016, USA.
    Fogel BL; Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.; Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.; UCLA Clinical Neurogenomics Research Center, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.
    Bronstein JM; Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA.; Brain Research Institute, University of California, Los Angeles, CA, 90095, USA.
    Ritz B; Department of Epidemiology, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, 90095, USA.; Brain Research Institute, University of California, Los Angeles, CA, 90095, USA.
    Bitan G; Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA. .; Brain Research Institute, University of California, Los Angeles, CA, 90095, USA. .; Molecular Biology Institute, University of California Los Angeles, Los Angeles, CA, 90095, USA. .
    Pokaż więcej
    Źródło:
    Translational neurodegeneration [Transl Neurodegener] 2023 Mar 20; Vol. 12 (1), pp. 14. Date of Electronic Publication: 2023 Mar 20.
    Typ publikacji:
    Letter; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
    MeSH Terms:
    Parkinson Disease*/diagnosis
    Multiple System Atrophy*/diagnosis
    Extracellular Vesicles*
    Humans ; Diagnosis, Differential ; Biomarkers
    Raport
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Rehabilitation of Airway Protection in Individuals With Movement Disorders: A Telehealth Feasibility Study.
    Autorzy:
    Sevitz JS; Laboratory for the Study of Upper Airway Dysfunction, Department of Biobehavioral Sciences, Teachers College, Columbia University, New York, NY.
    Borders JC; Laboratory for the Study of Upper Airway Dysfunction, Department of Biobehavioral Sciences, Teachers College, Columbia University, New York, NY.
    Dakin AE; Laboratory for the Study of Upper Airway Dysfunction, Department of Biobehavioral Sciences, Teachers College, Columbia University, New York, NY.
    Kiefer BR; Department of Speech, Language, and Hearing Sciences, Purdue University, West Lafayette, IN.
    Alcalay RN; Department of Neurology, Columbia University Irving Medical Center, New York, NY.; Department of Neurology, Tel Aviv Sourasky Medical Center, Israel.
    Kuo SH; Department of Neurology, Columbia University Irving Medical Center, New York, NY.
    Troche MS; Laboratory for the Study of Upper Airway Dysfunction, Department of Biobehavioral Sciences, Teachers College, Columbia University, New York, NY.; Department of Neurology, Columbia University Irving Medical Center, New York, NY.
    Pokaż więcej
    Źródło:
    American journal of speech-language pathology [Am J Speech Lang Pathol] 2022 Nov 16; Vol. 31 (6), pp. 2741-2758. Date of Electronic Publication: 2022 Oct 24.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Movement Disorders*
    Telemedicine*
    Humans ; Respiratory Muscles ; Feasibility Studies ; Cough ; Quality of Life
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson's Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial.
    Autorzy:
    Peterschmitt MJ; Sanofi, Cambridge, MA, USA.
    Saiki H; Kitano Hospital, The Tazuke Kofukai Medical Research Institute, Osaka, Japan.
    Hatano T; Juntendo University, Tokyo, Japan.
    Gasser T; Neurologische Universitätsklinik, Tübingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
    Isaacson SH; Parkinson's Disease and Movement Disorders Center, Boca Raton, FL, USA.
    Gaemers SJM; Sanofi Genzyme, Amsterdam, Netherlands.
    Minini P; Sanofi, Chilly-Mazarin, France.
    Saubadu S; Sanofi, Chilly-Mazarin, France.
    Sharma J; Sanofi, Bridgewater, NJ, USA.
    Walbillic S; Sanofi, Chilly-Mazarin, France.
    Alcalay RN; Department of Neurology and the Taub Institute, Columbia University Medical Center, New York, NY, USA.
    Cutter G; University of Alabama at Birmingham, School of Public Health, Birmingham, AL, USA.
    Hattori N; Juntendo University, Tokyo, Japan.
    Höglinger GU; German Center for Neurodegenerative Diseases (DZNE), Munich, and Department of Neurology, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany.; Department of Neurology, Hannover Medical School, Hannover, Germany.
    Marek K; Institute for Neurodegenerative Disorders, New Haven, CT, USA.
    Schapira AHV; Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK.
    Scherzer CR; Harvard Medical School and Brigham & Women's Hospital, Boston, MA, USA.
    Simuni T; Northwestern University, Chicago, IL, USA.
    Giladi N; Neurological Institute, Tel Aviv Medical Center, Sackler School of Medicine, Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
    Sardi SP; Sanofi, Cambridge, MA, USA.
    Fischer TZ; Sanofi, Cambridge, MA, USA.
    Pokaż więcej
    Corporate Authors:
    MOVES-PD Investigators
    Źródło:
    Journal of Parkinson's disease [J Parkinsons Dis] 2022; Vol. 12 (2), pp. 557-570.
    Typ publikacji:
    Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Glucosylceramidase*/genetics
    Parkinson Disease*/drug therapy
    Parkinson Disease*/genetics
    Adolescent ; Adult ; Aged ; Aged, 80 and over ; Enzyme Inhibitors/adverse effects ; Glucosylceramides ; Humans ; Middle Aged ; Mutation ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Subnormal GM1 in PBMCs: Promise for Early Diagnosis of Parkinson's Disease?
    Autorzy:
    Alselehdar SK; Department of Pharmacology, Physiology, and Neuroscience, Rutgers, The State University of NJ, Newark, NJ 07103, USA.
    Chakraborty M; Department of Pharmacology, Physiology, and Neuroscience, Rutgers, The State University of NJ, Newark, NJ 07103, USA.
    Chowdhury S; Department of Pharmacology, Physiology, and Neuroscience, Rutgers, The State University of NJ, Newark, NJ 07103, USA.
    Alcalay RN; Department of Neurology, Columbia University Irving Medical Center, New York, NY 10032, USA.
    Surface M; Department of Neurology, Columbia University Irving Medical Center, New York, NY 10032, USA.
    Ledeen R; Department of Pharmacology, Physiology, and Neuroscience, Rutgers, The State University of NJ, Newark, NJ 07103, USA.
    Pokaż więcej
    Źródło:
    International journal of molecular sciences [Int J Mol Sci] 2021 Oct 26; Vol. 22 (21). Date of Electronic Publication: 2021 Oct 26.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    G(M1) Ganglioside/*blood
    G(M1) Ganglioside/*deficiency
    Parkinson Disease/*blood
    Parkinson Disease/*diagnosis
    Aged ; Biomarkers/blood ; Blood Chemical Analysis ; Case-Control Studies ; Early Diagnosis ; Female ; Gangliosides/blood ; Glucosylceramidase/genetics ; Humans ; Leukocytes, Mononuclear/metabolism ; Male ; Middle Aged ; Mutation ; Parkinson Disease/genetics ; ROC Curve
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Lipidomics Prediction of Parkinson's Disease Severity: A Machine-Learning Analysis.
    Autorzy:
    Avisar H; Department of Industrial Engineering & Management, Ben-Gurion University of the Negev, Israel.
    Guardia-Laguarta C; Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
    Area-Gomez E; Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
    Surface M; Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
    Chan AK; Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
    Alcalay RN; Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
    Lerner B; Department of Industrial Engineering & Management, Ben-Gurion University of the Negev, Israel.
    Pokaż więcej
    Źródło:
    Journal of Parkinson's disease [J Parkinsons Dis] 2021; Vol. 11 (3), pp. 1141-1155.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Lipidomics*
    Parkinson Disease*/diagnosis
    Biomarkers ; Female ; Humans ; Lipids ; Machine Learning ; Male ; Severity of Illness Index
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Longitudinal Measurements of Glucocerebrosidase activity in Parkinson's patients.
    Autorzy:
    Alcalay RN; Department of Neurology, Columbia University Irving Medical Center New York, New York, USA.
    Wolf P; Translational Sciences, Sanofi, Framingham, Massachusetts, USA.
    Chiang MSR; Rare and Neurological Diseases Therapeutic Area, Sanofi, Framingham, Massachusetts, USA.
    Helesicova K; Translational Sciences, Sanofi, Framingham, Massachusetts, USA.
    Zhang XK; Translational Sciences, Sanofi, Framingham, Massachusetts, USA.
    Merchant K; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
    Hutten SJ; The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA.
    Scherzer C; Advanced Center for Parkinson's Disease Research of Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Precision Neurology Program, Harvard Medical School, Brigham & Women's Hospital, Boston, Massachusetts, USA.; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
    Caspell-Garcia C; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA.
    Blauwendraat C; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
    Foroud T; Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
    Nudelman K; Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
    Gan-Or Z; Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.; Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada.; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
    Simuni T; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
    Chahine LM; Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
    Levy O; Department of Neurology, Columbia University Irving Medical Center New York, New York, USA.
    Zheng D; Department of Biostatistics, Mailman School of Public Health, Columbia University Irving Medical Center New York, New York, USA.
    Li G; Department of Biostatistics, Mailman School of Public Health, Columbia University Irving Medical Center New York, New York, USA.
    Sardi SP; Rare and Neurological Diseases Therapeutic Area, Sanofi, Framingham, Massachusetts, USA.
    Pokaż więcej
    Corporate Authors:
    Parkinson’s Progression Markers Initiative
    Źródło:
    Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2020 Oct; Vol. 7 (10), pp. 1816-1830. Date of Electronic Publication: 2020 Sep 05.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Dementia/*physiopathology
    Glucosylceramidase/*metabolism
    Parkinson Disease/*metabolism
    Parkinson Disease/*pathology
    Adult ; Dementia/complications ; Dementia/pathology ; Disease Progression ; Female ; Genotype ; Glucosylceramidase/genetics ; Heterozygote ; Humans ; Male ; Mental Status and Dementia Tests ; Middle Aged ; Mutation/genetics ; Parkinson Disease/complications ; Phenotype
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Impact of the COVID-19 Pandemic on Parkinson's Disease and Movement Disorders.
    Autorzy:
    Papa SM; Yerkes National Primate Research Center, Department of Neurology Emory University School of Medicine Atlanta Georgia USA.
    Brundin P; Van Andel Institute, Center for Neurodegenerative Science Grand Rapids Michigan USA.
    Fung VSC; Movement Disorders Unit, Department of Neurology Westmead Hospital and Sydney Medical School, University of Sydney Sydney NSW Australia.
    Kang UJ; Department of Neurology New York University Grossman School of Medicine New York New York USA.
    Burn DJ; Department of Medical Sciences Newcastle University Medical School Newcastle United Kingdom.
    Colosimo C; Department of Neurology Santa Maria University Hospital Terni Italy.
    Chiang HL; Department of Neurology Neurological Institute, Taipei Veterans General Hospital Taipei Taiwan.
    Alcalay RN; Department of Neurology Columbia University Irving Medical Center New York New York USA.
    Trenkwalder C; Paracelsus-Elena Klinik, Kassel, Department of Neurosurgery University Medical Center Goettingen Goettingen Germany.
    Pokaż więcej
    Corporate Authors:
    MDS‐Scientific Issues Committee
    Źródło:
    Movement disorders clinical practice [Mov Disord Clin Pract] 2020 Apr 16; Vol. 7 (4), pp. 357-360. Date of Electronic Publication: 2020 Apr 16 (Print Publication: 2020).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease.
    Autorzy:
    Weintraub D; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Parkinson's Disease Research, Education and Clinical Center, Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania.
    Caspell-Garcia C; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa.
    Simuni T; Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
    Cho HR; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa.
    Coffey CS; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa.
    Aarsland D; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, England.
    Alcalay RN; Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York.
    Barrett MJ; Department of Neurology, Virginia Commonwealth University, Richmond, Virginia.
    Chahine LM; Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
    Eberling J; Michael J. Fox Foundation for Parkinson's Research, New York, New York.
    Espay AJ; Department of Neurology, University of Cincinnati Academic Health Center, Cincinnati, Ohio.
    Hamilton J; Michael J. Fox Foundation for Parkinson's Research, New York, New York.
    Hawkins KA; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut.
    Leverenz J; Lou Ruvo Center for Brain Health, Cleveland Clinic, Cleveland, Ohio.
    Litvan I; UCSD Movement Disorder Center, Department of Neurosciences, University of California San Diego, San Diego, California.
    Richard I; Departments of Neurology and Psychiatry, School of Medicine and Dentistry, University of Rochester, Rochester, New York.
    Rosenthal LS; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
    Siderowf A; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
    York M; Departments of Neurology and Psychiatry & Behavioral Sciences, Baylor College of Medicine, Houston, Texas.
    Pokaż więcej
    Corporate Authors:
    Parkinson’s Progression Markers Initiative
    Źródło:
    Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2020 Apr; Vol. 7 (4), pp. 449-461. Date of Electronic Publication: 2020 Apr 13.
    Typ publikacji:
    Journal Article; Observational Study; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Disease Progression*
    Behavioral Symptoms/*physiopathology
    Cognitive Dysfunction/*physiopathology
    Parkinson Disease/*physiopathology
    Adult ; Aged ; Aged, 80 and over ; Behavioral Symptoms/drug therapy ; Behavioral Symptoms/epidemiology ; Behavioral Symptoms/etiology ; Cognitive Dysfunction/drug therapy ; Cognitive Dysfunction/epidemiology ; Cognitive Dysfunction/etiology ; Female ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Parkinson Disease/complications ; Parkinson Disease/drug therapy ; Parkinson Disease/epidemiology ; Prevalence
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Cerebrospinal fluid proteomics implicates the granin family in Parkinson's disease.
    Autorzy:
    Rotunno MS; Rare and Neurologic Diseases Therapeutic Area, Sanofi, Inc., Framingham, MA, 01701, USA.; Biomarkers and Bioanalytics, Translational Sciences, Sanofi, Inc., Framingham, MA, 01701, USA.
    Lane M; Biomarkers and Bioanalytics, Translational Sciences, Sanofi, Inc., Framingham, MA, 01701, USA.
    Zhang W; Translational Medicine, Sanofi, Inc., Framingham, MA, 01701, USA.
    Wolf P; Biomarkers and Bioanalytics, Translational Sciences, Sanofi, Inc., Framingham, MA, 01701, USA.; Editas Medicine, Cambridge, MA, 02141, USA.
    Oliva P; Biomarkers and Bioanalytics, Translational Sciences, Sanofi, Inc., Framingham, MA, 01701, USA.; ARCHIMED Life Sciences GmbH, Leberstraße 20/2, 1110, Vienna, Austria.
    Viel C; Rare and Neurologic Diseases Therapeutic Area, Sanofi, Inc., Framingham, MA, 01701, USA.
    Wills AM; Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA.
    Alcalay RN; Department of Neurology, Columbia University, New York, NY, 10032-3784, USA.
    Scherzer CR; Precision Neurology Program, Harvard Medical School, Brigham & Women's Hospital, Boston, MA, 02115, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA.; APDA Center for Advance Parkinson Research, Harvard Medical School, Brigham & Women's Hospital, Boston, MA, 02115, USA.
    Shihabuddin LS; Rare and Neurologic Diseases Therapeutic Area, Sanofi, Inc., Framingham, MA, 01701, USA.
    Zhang K; Biomarkers and Bioanalytics, Translational Sciences, Sanofi, Inc., Framingham, MA, 01701, USA.; Editas Medicine, Cambridge, MA, 02141, USA.
    Sardi SP; Rare and Neurologic Diseases Therapeutic Area, Sanofi, Inc., Framingham, MA, 01701, USA. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2020 Feb 12; Vol. 10 (1), pp. 2479. Date of Electronic Publication: 2020 Feb 12.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Chromogranins/*cerebrospinal fluid
    Parkinson Disease/*cerebrospinal fluid
    Aged ; Biomarkers/cerebrospinal fluid ; Female ; Humans ; Male ; Middle Aged ; Proteomics ; Tandem Mass Spectrometry
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    A Virtual Cohort Study of Individuals at Genetic Risk for Parkinson's Disease: Study Protocol and Design.
    Autorzy:
    Schneider RB; Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA.; Center for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.
    Myers TL; Center for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.
    Rowbotham HM; 23andMe, Inc., Sunnyvale, CA, USA.
    Luff MK; 23andMe, Inc., Sunnyvale, CA, USA.
    Amodeo K; Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA.
    Sharma S; Center for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.
    Wilson R; Center for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.
    Jensen-Roberts S; Center for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.
    Auinger P; Center for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.
    McDermott MP; Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA.; Center for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.; Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY, USA.
    Alcalay RN; Department of Neurology, Columbia University, New York, NY, USA.
    Biglan K; Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA.; Eli Lilly and Company, Indianapolis, IN, USA.
    Kinel D; Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA.; Center for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.
    Tanner C; Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
    Winter-Evans R; Valley Oaks Health, Lafayette, IN, USA.
    Augustine EF; Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA.; Center for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.
    Cannon P; 23andMe, Inc., Sunnyvale, CA, USA.
    Holloway RG; Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA.
    Dorsey ER; Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA.; Center for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.
    Pokaż więcej
    Corporate Authors:
    23andMe Research Team
    Źródło:
    Journal of Parkinson's disease [J Parkinsons Dis] 2020; Vol. 10 (3), pp. 1195-1207.
    Typ publikacji:
    Journal Article; Observational Study; Research Support, N.I.H., Extramural
    MeSH Terms:
    Clinical Protocols*
    Clinical Trials as Topic*
    Genetic Predisposition to Disease*
    Research Design*
    Telemedicine*
    Parkinson Disease/*diagnosis
    Parkinson Disease/*genetics
    Aged ; Cohort Studies ; Feasibility Studies ; Female ; Genetic Testing ; Heterozygote ; Humans ; Jews/genetics ; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2/genetics ; Longitudinal Studies ; Male ; Middle Aged ; Parkinson Disease/therapy ; Rare Diseases
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson's Disease and G2019S LRRK2 Cohorts.
    Autorzy:
    Padmanabhan S; The Michael J Fox Foundation for Parkinson's Research, NY, USA.
    Lanz TA; Pfizer Inc., Groton, CT, USA.
    Gorman D; Pfizer Inc., Cambridge, UK.
    Wolfe M; Quanterix, Billerica, MA, USA.
    Joyce A; Pfizer Inc., Andover, MA, USA.
    Cabrera C; Pfizer Inc., Andover, MA, USA.
    Lawrence-Henderson R; Pfizer Inc., Andover, MA, USA.
    Levers N; Department of Neurology, Columbia University, NY, USA.
    Joshi N; Department of Neurology, Columbia University, NY, USA.
    Ma TC; Department of Neurology, Columbia University, NY, USA.
    Liong C; Department of Neurology, Columbia University, NY, USA.
    Narayan S; Department of Neurology, Columbia University, NY, USA.
    Alcalay RN; Department of Neurology, Columbia University, NY, USA.
    Hutten SJ; The Michael J Fox Foundation for Parkinson's Research, NY, USA.
    Baptista MAS; The Michael J Fox Foundation for Parkinson's Research, NY, USA.
    Merchant K; TransThera Consulting Co, Portland, OR, USA.
    Pokaż więcej
    Źródło:
    Journal of Parkinson's disease [J Parkinsons Dis] 2020; Vol. 10 (2), pp. 623-629.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Leucine-Rich Repeat Serine-Threonine Protein Kinase-2/*metabolism
    Leukocytes, Mononuclear/*metabolism
    Parkinson Disease/*blood
    Parkinson Disease/*genetics
    Adult ; Aged ; Aged, 80 and over ; Cohort Studies ; Female ; Humans ; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2/genetics ; Male ; Middle Aged ; Phosphorylation/physiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Frequency of GBA variants in autopsy-proven multiple system atrophy.
    Autorzy:
    Sklerov M; Columbia University Medical Center, New York, New York.
    Kang UJ; Columbia University Medical Center, New York, New York.
    Liong C; Columbia University Medical Center, New York, New York.
    Clark L; Columbia University Medical Center, New York, New York.
    Marder K; Columbia University Medical Center, New York, New York.
    Pauciulo M; Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati OH.
    Nichols WC; Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati OH.
    Chung WK; Columbia University Medical Center, New York, New York.
    Honig LS; Columbia University Medical Center, New York, New York.
    Cortes E; Columbia University Medical Center, New York, New York.
    Vonsattel JP; Columbia University Medical Center, New York, New York.
    Alcalay RN; Columbia University Medical Center, New York, New York.
    Pokaż więcej
    Źródło:
    Movement disorders clinical practice [Mov Disord Clin Pract] 2017 Jul-Aug; Vol. 4 (4), pp. 574-581. Date of Electronic Publication: 2017 Apr 03.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Elevated GM3 plasma concentration in idiopathic Parkinson's disease: A lipidomic analysis.
    Autorzy:
    Chan RB; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, United States of America.; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York, United States of America.
    Perotte AJ; Department of Biomedical Informatics, Columbia University Medical Center, New York, New York, United States of America.
    Zhou B; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, United States of America.
    Liong C; Department of Neurology, Columbia University Medical Center, New York, New York, United States of America.
    Shorr EJ; Department of Neurology, Columbia University Medical Center, New York, New York, United States of America.
    Marder KS; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York, United States of America.; Department of Neurology, Columbia University Medical Center, New York, New York, United States of America.
    Kang UJ; Department of Neurology, Columbia University Medical Center, New York, New York, United States of America.
    Waters CH; Department of Neurology, Columbia University Medical Center, New York, New York, United States of America.
    Levy OA; Department of Neurology, Columbia University Medical Center, New York, New York, United States of America.
    Xu Y; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, United States of America.; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York, United States of America.
    Shim HB; Department of Biomedical Informatics, Columbia University Medical Center, New York, New York, United States of America.
    Pe'er I; Department of Biomedical Informatics, Columbia University Medical Center, New York, New York, United States of America.
    Di Paolo G; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, United States of America.; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York, United States of America.
    Alcalay RN; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York, United States of America.; Department of Neurology, Columbia University Medical Center, New York, New York, United States of America.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2017 Feb 17; Vol. 12 (2), pp. e0172348. Date of Electronic Publication: 2017 Feb 17 (Print Publication: 2017).
    Typ publikacji:
    Journal Article
    MeSH Terms:
    G(M3) Ganglioside/*blood
    Parkinson Disease/*blood
    Aged ; Aged, 80 and over ; Biomarkers/blood ; Case-Control Studies ; Female ; Humans ; Male ; Middle Aged ; Parkinson Disease/physiopathology ; Sex Characteristics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    GBA mutations are associated with Rapid Eye Movement Sleep Behavior Disorder.
    Autorzy:
    Gan-Or Z; Montreal Neurological Institute, McGill University Montréal, Quebec, Canada ; Department of Human Genetics, McGill University Montréal, Quebec, Canada.
    Mirelman A; Department of Neurology, Tel-Aviv Sourasky Medical Center Tel-Aviv, Israel.
    Postuma RB; Department of Neurology, Montreal General Hospital Montréal, Quebec, Canada.
    Arnulf I; Sleep Disorders Unit, Pitié Salpêtrière Hospital, Brain and Spine Institute and Sorbonne Universities, UPMC Paris 6 University Paris, France.
    Bar-Shira A; The Genetic Institute, Tel-Aviv Sourasky Medical Center Tel-Aviv, Israel.
    Dauvilliers Y; Sleep Unit, National Reference Network for Narcolepsy, Department of Neurology, Hôpital-Gui-de Chauliac, CHU Montpellier Montpellier, France.
    Desautels A; Centre d'Études Avancées en Médecine du Sommeil, Hôpital du Sacré-Cœur de Montréal Montréal, Quebec, Canada ; Department of Neurosciences, Université de Montréal Montréal, Canada.
    Gagnon JF; Centre d'Études Avancées en Médecine du Sommeil, Hôpital du Sacré-Cœur de Montréal Montréal, Quebec, Canada ; Département de psychologie, Université du Québec à Montréal Montréal, Quebec, Canada.
    Leblond CS; Montreal Neurological Institute, McGill University Montréal, Quebec, Canada ; Department of Human Genetics, McGill University Montréal, Quebec, Canada.
    Frauscher B; Sleep Disorders Clinic, Department of Neurology, Innsbruck Medical University Innsbruck, Austria.
    Alcalay RN; Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University New York, New York.
    Saunders-Pullman R; Department of Neurology, Icahn School of Medicine at Mount Sinai New York, New York ; Department of Neurology, Albert Einstein College of Medicine Bronx New York, New York.
    Bressman SB; Department of Neurology, Beth Israel Medical Center New York, New York.
    Marder K; Columbia Presbyterian Medical Center, Columbia University New York, New York.
    Monaca C; Department of clinical neurophysiology and sleep center, University Lille north of France, CHU Lille Lille, France.
    Högl B; Sleep Disorders Clinic, Department of Neurology, Innsbruck Medical University Innsbruck, Austria.
    Orr-Urtreger A; The Genetic Institute, Tel-Aviv Sourasky Medical Center Tel-Aviv, Israel ; The Sackler Faculty of Medicine, Tel-Aviv University Tel-Aviv, Israel.
    Dion PA; Montreal Neurological Institute, McGill University Montréal, Quebec, Canada ; Department of Human Genetics, McGill University Montréal, Quebec, Canada ; Department of Neurology and Neurosurgery, McGill University Montréal, Quebec, Canada.
    Montplaisir JY; Centre d'Études Avancées en Médecine du Sommeil, Hôpital du Sacré-Cœur de Montréal Montréal, Quebec, Canada ; Department of Psychiatry, Université de Montréal Montréal, Quebec, Canada.
    Giladi N; Department of Neurology, Tel-Aviv Sourasky Medical Center Tel-Aviv, Israel ; The Sackler Faculty of Medicine, Tel-Aviv University Tel-Aviv, Israel.
    Rouleau GA; Montreal Neurological Institute, McGill University Montréal, Quebec, Canada ; Department of Human Genetics, McGill University Montréal, Quebec, Canada ; Department of Neurology and Neurosurgery, McGill University Montréal, Quebec, Canada.
    Pokaż więcej
    Źródło:
    Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2015 Sep; Vol. 2 (9), pp. 941-5. Date of Electronic Publication: 2015 Jul 31.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker?
    Autorzy:
    Saunders-Pullman R; Department of Neurology, Mount Sinai Beth Israel Medical Center New York City, New York ; Department of Neurology, Icahn School of Medicine at Mount Sinai New York City, New York ; Department of Neurology, Albert Einstein College of Medicine Bronx, New York.
    Mirelman A; Movement Disorders Unit, Department of Neurology, Tel-Aviv Medical Center, Sackler School of Medicine, Sagol School of Neuroscience, Tel-Aviv University Tel-Aviv, Israel.
    Wang C; Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine Bronx, New York.
    Alcalay RN; Department of Neurology, College of Physicians and Surgeons, Columbia University New York City, New York ; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University New York City, New York.
    San Luciano M; Department of Neurology, University of California San Francisco San Francisco, California.
    Ortega R; Department of Neurology, Mount Sinai Beth Israel Medical Center New York City, New York.
    Raymond D; Department of Neurology, Mount Sinai Beth Israel Medical Center New York City, New York.
    Mejia-Santana H; Department of Neurology, College of Physicians and Surgeons, Columbia University New York City, New York ; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University New York City, New York.
    Ozelius L; Department of Neurology, Icahn School of Medicine at Mount Sinai New York City, New York ; Department of Genetics, Icahn School of Medicine at Mount Sinai New York City, New York.
    Clark L; Department of Neurology, College of Physicians and Surgeons, Columbia University New York City, New York ; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University New York City, New York.
    Orr-Utreger A; Genetic Institute, Tel-Aviv Medical Center, Sackler School of Medicine, Sagol School of Neuroscience, Tel-Aviv University Tel-Aviv, Israel.
    Marder K; Department of Neurology, College of Physicians and Surgeons, Columbia University New York City, New York ; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University New York City, New York ; Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University New York City, New York ; Department of Psychiatry, Columbia University Medical Center New York City, New York.
    Giladi N; Movement Disorders Unit, Department of Neurology, Tel-Aviv Medical Center, Sackler School of Medicine, Sagol School of Neuroscience, Tel-Aviv University Tel-Aviv, Israel.
    Bressman SB; Department of Neurology, Mount Sinai Beth Israel Medical Center New York City, New York ; Department of Neurology, Icahn School of Medicine at Mount Sinai New York City, New York.
    Pokaż więcej
    Źródło:
    Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2014 Sep; Vol. 1 (9), pp. 670-8. Date of Electronic Publication: 2014 Sep 30.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease.
    Autorzy:
    Alcalay RN; Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
    Mejia-Santana H
    Tang MX
    Rakitin B
    Rosado L
    Ross B
    Verbitsky M
    Kisselev S
    Louis ED
    Comella CL
    Colcher A
    Jennings D
    Nance MA
    Bressman S
    Scott WK
    Tanner C
    Mickel SF
    Andrews HF
    Waters CH
    Fahn S
    Cote LJ
    Frucht SJ
    Ford B
    Rezak M
    Novak K
    Friedman JH
    Pfeiffer R
    Marsh L
    Hiner B
    Siderowf A
    Ottman R
    Clark LN
    Marder KS
    Caccappolo E
    Pokaż więcej
    Źródło:
    Journal of clinical and experimental neuropsychology [J Clin Exp Neuropsychol] 2010 Aug; Vol. 32 (7), pp. 775-9. Date of Electronic Publication: 2010 Feb 24.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Cognition Disorders/*genetics
    Cognition Disorders/*psychology
    Glucosylceramidase/*genetics
    Parkinson Disease/*genetics
    Parkinson Disease/*psychology
    Protein Serine-Threonine Kinases/*genetics
    Ubiquitin-Protein Ligases/*genetics
    Heterozygote ; Humans ; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 ; Logistic Models ; Mutation/genetics ; Mutation/physiology ; Neuropsychological Tests
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-17 z 17

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies